See also this year's filing and all EDGAR filings for this company.
PDF Report 0000849636_2023_RespireRx_Pharmaceuticals_Inc.pdf
Logs
| error | IME and Company effects mismatched for Liabilities, Current. IME Effects: 203.0, Company Effect: 204.0 | subcommand.report | {} |
| warning | Missing logo | subcommand.report | {} |
| info | original effects; company_effects: 203.5, ime_effects: 203 | subcommand.report | {} |
Graph
Absolute values for 0000849636, RespireRx Pharmaceuticals Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 22,781 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 11,729,101 |
| 5 | LiabilitiesNoncurrent | 174,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 1,149,823 |
| 9 | ResearchAndDevelopmentExpense | 429,532 |
| 10 | remainder_Expenses | 603,818 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 80,453 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 22,781 |
| 1 | Liabilities | 11,903,101 |
| 2 | Expenses | 2,183,173 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -11,880,320 |
| 5 | NetIncome | -2,102,720 |
| 6 | ComprehensiveNetIncome | -2,102,720 |
| 7 | BaseVar | 7,094,754 |
| 8 | EconomicCapitalRatio | -3.78 |
Edgar->Model Mapping
Feature Distribution
Change over Time
